Marine peptides and their anti-infective activities

Marine Drugs

Volumn 13, Issue 1, 2015, Pages 618-654

  Kang, Hee Kyoung ^a   Seo, Chang Ho ^b   Park, Yoonkyung ^a  

^a Chosun University   (South Korea)

^b Kongju National University   (South Korea)

Author keywords

Anti infective peptides; Antifungal; Antimicrobial; Antiviral; Marine organisms

Indexed keywords

ANTIINFECTIVE AGENT; ARENICIN 1; ARIAKEMICIN A; ARIAKEMICIN B; AURELIN; CALLIPELTIN DERIVATIVE; CENTROCIN 1; CENTROCIN 2; CLAVANIN; CYTOSPORONE B; DAMICORNIN; DRAGOMABIN; GALLINAMIDE A; HALOCIDIN; HALOCYNTIN; HOMOPHYMINE DERIVATIVE; HYASTAIN; HYASTATIN; INDIGOIDINE; KOSHIKAMIDE DERIVATIVE; MARINE PEPTIDE; MIRABAMIDE; NGERCHEUMICIN; PAPILLOSIN; PEDEIN A; PEPTIDE DERIVATIVE; SOLOMIDE; THEONELLAMIDE; TRICHODERIN DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTIFUNGAL AGENT; ANTIMALARIAL AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; ANTIPROTOZOAL AGENT; ANTIVIRUS AGENT;

AMINO ACID SEQUENCE; ANIMAL PRODUCT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ANTIMALARIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; ANTIVIRAL RESISTANCE; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; HUMAN; IC50; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REVIEW; ANIMAL; AQUATIC SPECIES; CHEMISTRY; ISOLATION AND PURIFICATION; SPONGE (PORIFERA);

ALGAE; ANIMALIA; FUNGI;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; ANTIMALARIALS; ANTIMICROBIAL CATIONIC PEPTIDES; ANTIPROTOZOAL AGENTS; ANTIVIRAL AGENTS; AQUATIC ORGANISMS; PORIFERA;

EID: 84921629400     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md13010618     Document Type: Review

References (116)

1. Mayer, A.M.; Rodriguez, A.D.; Berlinck, R.G.; Fusetani, N. Marine pharmacology in 2009-2013: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Mar Drugs 2013, 11, 2510-2573.
2. Masso-Silva, J.A.; Diamond, G. Antimicrobial Peptides from Fish. Pharmaceuticals 2014, 7, 265-310.
3. Winder, P.L.; Pomponi, S.A.; Wright, A.E. Natural Products from the Lithistida: A Review of the Literature since 2000. Mar. Drugs 2011, 9, 2643-2682.
4. Mayer, A.M.; Rodriguez, A.D.; Berlinck, R.G.; Fusetani, N. Marine pharmacology in 2007-2008: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis and antiviral activities; affecting the immune and nervous system and other miscellaneous mechanism of action. Comp. Biochem. Physiol. C Toxicol. Pharmacol . 2011, 153, 191-222.
5. Villa, F.A.; Gernwick, L. Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections and neurological disorders. Immunopharmacol. Immunotoxicol. 2010, 32, 228-237.
6. Blunt, J.W.; Copp, B.R.; Munso, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2011, 28, 196-268.
7. Zhou, X.; Liu, J.; Yang, B.; Lin, X.; Yang, X.W.; Liu, Y. Marine natural products with anti-HIV activities in the last decade. Curr. Med. Chem. 2013, 20, 953-973.
8. Kim, S.K.; Wijesekara, I. Development and biological activities of marine-derived bioactive peptides: A review. Curr. Protein Pept. Sci. 2010, 2, 1-9.
9. Ngo, D.H.; Vo, T.S.; Ngo, D.N.; Wijesekara, I.; Kim, S.K. Biological activities and potential health benefits of bioactive peptides derived from marine organisms. Int. J. Biol. Macromol. 2012, 51, 378-383.
10. Laport, M.S.; Santos, D.C.; Muricy, G. Marine sponges: Potential sources of new antimicrobial drugs. Curr. Pharm. Biotechnol. 2009, 10, 86-105.
11. Sagar, S.; Kaur, M.; Minneman, K.P. Antiviral lead compounds from marine sponges. Mar. Drugs 2010, 8, 2619-2638.
12. Cardozo, K.H.M.; Guaratini, T.; Barros, M.P.; Falcao, V.R.; Tonon, A.P.; Lopes, N.P.; Campos, S.; Torres, M.A.; Souza, A.D.; Colepicolo, P.; et al. Metabolites from algae with economical impact. Comp. Biochem. Physiol. Part C 2007, 146, 60-78.
13. nd ed.; Prentice-Hall Inc.: Englewood Cliffs, NJ, USA, 1985; pp. 1-33.
14. Garson, J. Marine natural products. Nat. Prod. Rep. 1989, 6, 143-170.
15. Nair, R.; Chabbadiya, R.; Chanda, S. Marine algae: Screening for a potent antibacterial agent. Int. J. Herb. Pharmacother. 2007, 7, 73-86.
16. Raja, A.; Vipin, C.; Aiyappan, A. Biological importance of Marine Algae-An overview. Int. J. Curr. Microbiol. Appl. Sci. 2013, 2, 222-227.
17. Nunnery, J.K.; Mevers, E.; Gerwick, W.H. Biologically active secondary metabolites from marine cyanobacteria. Curr. Opin. Biotechnol. 2010, 21, 787-793.
18. Cabrita, M.T.; Vale, C.; Router, A.P. Halogenated compounds from marine algae. Mar. Drugs 2010, 8, 2301-2317.
19. El Gamal, A.A. Biological importance of marine algae. Saudi. Pharm. J. 2010, 18, 1-25.
20. st ed.; Mendez-Vilas, A., Ed.; FORMATEX: Badajoz, Spain, 2011; Volume 51, pp. 1293-1306.
21. Ananya, A.K.; Iffat, Z.A. Cyanobacteria "the blue green algae" and its novel applications: A brief review. Int. J. Innov. Appl. Stud. 2014, 7, 251-261.
22. Tan, L.T. Bioactive natural products from marine cyanobacteria for drug discovery. Phytochemistry 2007, 68, 954-979.
23. Jaiganesh, R.; Sampath Kumar, N.S. Marine bacterial sources of bioactive compounds. Adv. Food Nutr. Res. 2012, 65, 389-408.
24. Debbab, A.; Aly, A.H.; Lin, W.H.; Proksch, P. Bioactive compounds from marine bacteria and fungi. Microb. Biotechnol. 2010, 3, 544-563.
25. Waters, A.L.; Hill, R.T.; Place, A.R.; Hamann, M.T. The expanding role of marine microbes in pharmaceutical development. Curr. Opin. Biotechnol. 2010, 21, 780-786.
26. Thomas, T.R.A.; Kaulekar, D.P.; Lokabarathi, P.A. Marine drugs from sponge-microbe association: A review. Mar. Drugs 2010, 8, 1417-1468.
27. Lu, X.; Gao, X.; Liu, X.; Jiao, B. Marine microbes-derived anti-bacterial agents. Mini Rev. Med. Chem. 2010, 10, 1077-1090.
28. Rahman, H.; Austin, B.; Mitchell, W.J.; Morris, P.C.; Jamieson, A.J.; Adams, D.R.; Spragg, A.M.; Schweizer, M. Novel anti-infective compounds from marine bacteria. Mar. Drugs 2010, 8, 498-518.
29. Suarez-Jimenez, G.M.; Burgos-Hernandez, A.; Ezquerra-Brauer. J.M. Bioactive peptides and depsipeptides with anticancer potential: Sources from marine animals. Mar. Drugs 2012, 10, 963-986.
30. Brinkman, D.L.; Aziz, A.; Loukas, A.; Potriquet, J.; Seymour, J.; Mulvenna, J. Venom proteome of the box jellyfish Chironex fleckeri. PLoS One 2012, 7, e47866.
31. Ovchinnikova, T.V.; Balandin, S.V.; Aleshina, G.M.; Tagaev, A.A.; Leonova, Y.F.; Krasnodembsky, E.D.; Men'shenin, A.V.; Kokryakov, V.N. Aurelin, a novel antimicrobial peptide from jellyfish Aurelia aurita with structural features of defensins and channel-blocking toxins. Biochem. Biophys. Res. Commun. 2006, 348, 514-523.
32. Lee, J.U.; Kang, D.I.; Zhu, W.L.; Shin, S.Y.; Hahm, K.S.; Kim, Y.; Solution structures and biological functions of the antimicrobial peptide, arenicin-1, and its linear derivative. Biopolymers 2007, 88, 208-216.
33. Balandin, S.V.; Zhmak, M.N.; Kudelina, I.A.; Finkina, E.I.; Kokryakov, V.N.; Arseniev, A.S. Recombinant expression, synthesis, purification, and solution structure of arenicin. Biochem. Biophys. Res. Commun. 2007, 360, 1561-1562.
34. Desjardine, K.; Pereira, A.; Wright, H.; Matainaho, T.; Kelly, M.; Andersen, R.J. Tauramamide, a lipopeptide antibiotic produced in culture by Brevibacillus laterosporus isolated from a marine habitat: Structure elucidation and synthesis. J. Nat. Prod. 2007, 70, 1850-1853.
35. Huang, P.H.; Chen, J.Y.; Kuo, C.M. Three different hepcidins from tilapia, Oreochromis mossambicus: Analysis of their expressions and biological functions. Mol. Immunol. 2007, 44, 1922-1934.
36. Huang, W.S.; Wang, K.J.; Yang, M.; Cai, J.J.; Li, S.J.; Wang, G.Z. Purification and part characterization of a novel antibacterial protein scygonadin, isolated from the seminal plasma of mud crab, Scylla serrata (Forskal). J. Exp. Mar. Bio. Ecol. 2006, 339, 37-42.
37. Wang, K.J.; Huang, W.S.; Yang, M.; Chen, H.Y.; Bo, J.; Li, S.J.; Wang, G.Z. A malespecific expression gene, encodes a novel anionic antimicrobial peptide, scygonadin, in Scylla serrata. Mol. Immunol . 2007, 44, 1961-1968.
38. Cai, M.; Sugumaran, M.; Robinson, W.E. The crosslinking and antimicrobial properties of tunichrome. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2008, 151, 110-117.
39. Sugumaran, M.; Robinson, W.E. Structure, biosynthesis and possible function of tunichromes and related compounds. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2012, 163, 1-25.
40. Pettit, G.R.; Knight, J.C.; Herald, D.L.; Pettit, R.K.; Hogan, F.; Mukku, V.J.; Hamblin, J.S.; Dodson, M.J.; Chapuis, J.C. Antineoplastic agents. Isolation and structure elucidation of bacillistatins 1 and 2 from a marine Bacillus silvestris. J. Nat. Prod. 2009, 72, 366-371.
41. Engelhardt, K.; Degnes, K.F.; Kemmler, M.; Bredholt, H.; Fjaervik, E.; Klinkenberg, G.; Sletta, H.; Ellingsen, T.E.; Zotchev, S.B. Production of a new thiopeptide antibiotic, TP-1161, by a marine Nocardiopsis species. Appl. Environ. Microbiol. 2010, 76, 4969-4976.
42. Li, C.; Haug, T.; Moe, M.K.; Styrvold, O.B.; Stensvag, K. Centrocins: Isolation and characterization of novel dimeric antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis. Dev. Comp. Immunol. 2010, 34, 959-968.
43. Galinier, R.; Roger, E.; Sautiere, P.E.; Aumelas, A.; Banaigs, B.; Mitta, G. Halocyntin and papillosin, two new antimicrobial peptides isolated from hemocytes of the solitary tunicate, Halocynthia papillosa. J. Pept. Sci. 2009, 15, 48-55.
44. Sperstad, S.V.; Haug, T.; Vasskog, T.; Stensvag, K. Hyastatin, a glycine-rich multi-domain antimicrobial peptide isolated from the spider crab (Hyas araneus) hemocytes. Mol. Immunol . 2009, 46, 2604-2612.
45. Slightom, R.N.; Buchan, A. Surface colonization by marine roseobacters: Integrating genotype and phenotype. Appl. Environ. Microbiol. 2009, 75, 6027-6037.
46. Oku, N.; Kawabata, K.; Adachi, K.; Katsuta, A.; Shizuri, Y. Unnarmicins A and C, new antibacterial depsipeptides produced by marine bacterium Photobacterium sp. MBIC06485. J. Antibiot . 2008, 61, 11-17.
47. Adachi, K.; Kawabata, Y.; Kasai, H.; Katsuta, M.; Shizuri, Y. Novel Ngercheumicin or its salt useful for treating infection caused by Pseudovibrio denitrificans. Japanese Patent JP2007230911-A, 13 September 2007.
48. Mansson, M.; Gram, L.; Larsen, T.O. Production of bioactive secondary metabolites by marine Vibrionaceae . Mar. Drugs 2011, 9, 1440-1468.
49. Rungprom, W.; Siwu, E.R.O.; Lambert, L.K.; Dechsakulwatana, C.; Barden, M.C.; Kokpol, U.; Blanchfield, J.T.; Kita, M.; Garson, M.J. Cyclic tetrapeptides from marine bacteria associated with the seaweed Diginea sp. and the sponge Halisarca ectofibrosa. Tetrahedron 2008, 64, 3147-3152.
50. Oku, N.; Adachi, K.; Matsuda, S.; Kasai, H.; Takatsaki, A.; Shizuri, Y. Ariakemicins A and B, novel polyketide-peptide antibiotics from a marine gliding bacterium of the genus Rapidithrix. Org. Lett . 2008, 10, 2481-2484.
51. Vidal-Dupiol, J.; Ladriere, O.; Destoumieux-Garzon, D.; Sautiere P.E.; Meistertzheim, A.L.; Tambutte, E.; Tambutte, S.; Duval, D.; Foure, L.; Adjeroud, M.; et al. Innate immune responses of a scleractinian coral to vibriosis. J. Biol. Chem. 2011, 286, 22688-22698.
52. Saude, A.C.; Ombredane, A.S.; Silva, O.N.; Barbosa, J.A.; Moreno, S.E.; Guerra Araujo, A.C.; Falcão, R.; Silva, L.P.; Dias, S.C.; Franco, O.L. Clavanin bacterial sepsis control using a novel methacrylate nanocarrier. Int. J. Nanomed. 2014, 9, 5055-5069.
53. Wang, W,; Kim, H.; Nam, S.J.; Rho, B.J.; Kang, H. Antibacterial butenolides from the Korean tunicate Pseudodistoma antinboja. J. Nat. Prod. 2012, 75, 2049-2054.
54. Beau, J.; Mahid. N.; Burda, W.N.; Harrington, L.; Shaw, L.N.; Mutka, T.; Kyle, D.E.; Barisic, B.; van Olphen, A.; Baker, B.J. Epigenetic tailoring for the production of anti-infective cytosporones from the marine fungus Leucostoma persoonii . Mar. Drugs 2012, 10, 762-774.
55. Jang, K.H.; Nam, S.J.; Locke, J.B.; Kauffman, C.A.; Beatty, D.S.; Paul, L.A.; Fenical, W. Anthracimycin, a potent anthrax antibiotic from a marine-derived actinomycete. Angew Chem. Int. Ed. Engl. 2013, 52, 7822-7824.
56. Jang, W.S.; Kim, H.K.; Lee, K.Y.; Kim, S.A.; Han, Y.S.; Lee, I.H. Antifungal activity of synthetic peptide derived from halocidin, antimicrobial peptide from the tunicate, Halocynthia aurantium. FEBS Lett. 2006, 580, 1490-1496.
57. D'Auria, M.V.; Sepe, V.; D'Orsi, R.; Bellotta, F.; Debitus, C.; Zampella, A. Isolation and structural elucidation of callipeltins J-M: Antifungal peptides from the marine sponge Latrunculia sp. Tetrahedron 2007, 63, 131-140.
58. Kunze, B.; Böhlendorf, B.; Reichenbach, H.; Höfle, G. Pedein A and B: Production, isolation, structure elucidation and biological properties of new antifungal cyclopeptides from Chondromyces pediculatus (Myxobacteria). J. Antibiot. 2008, 61, 18-26.
59. Nishimura, S.; Arita, Y.; Honda, M.; Iwamoto, K.; Matsuyama, A.; Shirai, A.; Kawasaki, H.; Kakeya, H.; Kobayashi, T.; Matsunaga, S.; et al. Marine antifungal theonellamides target 3β-hydroxysterol to activate rho1 signaling. Nat. Chem. Biol. 2010, 6, 519-526.
60. Youssef, D.T.; Shaala, L.A.; Mohamed, G.A.; Badr, J.M.; Bamanie, F.H.; Ibrahim, S.R. Theonellamide G, a potent antifungal and cytotoxic bicyclic glycopeptide from the red sea marine sponge Theonella swinhoei. Mar. Drugs 2014, 12, 1911-1923.
61. Plaza, A.; Bifulco, G.; Keffer, J.L.; Lloyd, J.R.; Baker, H.L.; Bewley, C.A. Celebesides A-C and theopapuamides B-D, depsipeptides from an indonesian sponge that inhibit HIV-1 entry. J. Org. Chem. 2009, 74, 504-512.
62. Berrue, F.; Ibrahim, A.; Boland, P.; Kerr, R.G. Newly isolated marine Bacillus pumilus (SP21): A source of novel lipoamides and other antimicrobial agents. Pure Appl. Chem. 2009, 81, 1027-1031.
63. Song, B.; Rong, Y.J.; Zhao, M.X.; Chi, Z.M. Antifungal activity of the lipopeptides produced by Bacillus amyloliquefaciens anti-CA against Candida albicans isolated from clinic. Appl. Microbiol. Biotechnol. 2013, 97, 7141-7150.
64. Zhang, D.J.; Liu, R.F.; Li, Y.G.; Tao, L.M.; Tian, L, Two new antifungal cyclic lipopeptides from Bacillus marinus B-9987. Chem. Pharm. Bull. (Tokyo) 2010, 58, 1630-1634.
65. Ma, Z.; Wang, N.; Hu, J.; Wang, S. Isolation and characterization of a new iturinic lipopeptide, mojavensin A produced by a marinederived bacterium Bacillus mojavensis B0621A. J. Antibiot . (Tokyo) 2012, 65, 317-322.
66. Gao, J.; Hamann, M.T. Chemistry and biology of kahalalides. Chem. Rev. 2011, 111, 3208-3235.
67. Iizuka, T.; Fudou, R.; Jojima, Y.; Ogawa, S.; Yamanaka, S.; Inukai, Y.; Ojika, M. Miuraenamides A and B, novel antimicrobial cyclic depsipeptides from a new slightly halophilic myxobacterium: Taxonomy, production, and biological properties. J. Antibiot. 2006, 59, 385-391.
68. Ojika, M.; Inukai, Y.; Kito, Y.; Hirata, M.; Iizuka, T.; Fudou, R. Miuraenamides: Antimicrobial cyclic depsipeptides isolated from a rare and slightly halophilic myxobacterium. Chem. Asian J. 2008, 3, 126-133.
69. Ibrahim, S.R.; Min, C.C.; Teuscher, F.; Ebel, R.; Kakoschke, C.; Lin, W.; Wray, V.; Edrada-Ebel, R.; Proksch, P. Callyaerins A-F and H, new cytotoxic cyclic peptides from the Indionesian marine sponge Callyspongia aerizusa. Bioorg. Med. Chem. 2010, 18, 4947-4956.
70. McPhail, K.L.; Correa, J.; Linington, R.G.; Gonzalez, J.; Ortega-Barria, E.; Capson, T.L.; Gerwick, W.H., Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 2007, 70, 984-988.
71. Linington, R.G.; Gonzalez, J.; Urena, L.D.; Romero, L.I.; Ortega-Barria, E.; Gerwick, W.H. Venturamides A and B: Antimalarial constituents of the Panamanian marine cyanobacterium Oscillatoria sp. J. Nat. Prod. 2007, 70, 397-401.
72. Portmann, C.; Blom, J.F.; Gademann, K.; Juttner, F. Aerucyclamides A and B: Isolation and synthesis of toxic ribosomal heterocyclic Peptides from the Cyanobacterium Microcystis aeruginosa PCC 7806. J. Nat. Prod. 2008, 71, 1193-1196.
73. Ziemert, N.; Ishida, K.; Quillardet, P.; Bouchier, C.; Hertweck, C.; de Marsac, N.T.; Dittmann, E. Microcyclamide biosynthesis in two strains of Microcystis aeruginosa: From structure to genes and Vice Versa. Appl. Environ. Microbiol. 2008, 74, 1791-1797.
74. Linington, R.G.; Clark, B.R.; Trimble, E.E.; Almanza, A.; Urena, L.D.; Kyle, D.E.; Gerwick, W.H. Antimalarial peptides from marine cyanobacteria: Isolation and structural elucidation of gallinamide A. J. Nat. Prod. 2009, 72, 14-17.
75. Tripathi, A.; Puddick, J.; Prinsep, M.R.; Rottmann, M.; Tan, L.T. Lagunamides A and B: Cytotoxic and antimalarial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 2010, 73, 1810-1814.
76. Carroll, A.R.; Nash, B.D.; Duffy, S.; Avery, V.M. Albopunctatone, an antiplasmodial anthrone-anthraquinone from the Australian ascidian Didemnum albopunctatum. J. Nat. Prod. 2012, 75, 1206-1209.
77. Simmons, T.L.; Engene, N.; Urena, L.D.; Romero, L.I.; Ortega-Barria, E.; Gerwick, L.; Gerwick, W.H. Viridamides A and B, lipodepsipeptides with antiprotozoal activity from the marine cyanobacterium Oscillatoria nigro-viridis. J. Nat. Prod. 2008, 71, 1544-1550.
78. Sanchez, L.M.; Lopez, D.; Vesely, B.A.; Della Togna, G.; Gerwick, W.H.; Kyle, D.E.; Linington, R.G. Almiramides A-C: Discovery and Development of a New Class of Leishmaniasis Lead Compounds. J. Med. Chem. 2010, 53, 4187-4197.
79. Pimentel-Elardo, S.M.; Kozytska, S.; Bugni, T.S.; Ireland, C.M.; Moll, H.; Hentschel, U. Anti-parasitic compounds from Streptomyces sp. strains isolated from mediterranean sponges. Mar. Drugs 2010, 8, 373-380.
80. Watts, K.R.; Ratnam, J.; Ang, K.H.; Tenney, K.; Compton, J.E.; McKerrow, J.; Crews, P. Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi. Bioorg. Med. Chem. 2010, 18, 2566-2574.
81. Pruksakorn, P.; Arai, M.; Kotoku, N.; Vilcheze, C.; Baughn, A.D.; Moodley, P.; Jacobs, W.R., Jr.; Kobayashi, M. Trichoderins, novel aminolipopeptides from a marine sponge-derived Trichoderma sp., are active against dormant mycobacteria. Bioorg. Med. Chem. Lett . 2010, 20, 3658-3663.
82. Plaza, A.; Gustchina, E.; Baker, H.L.; Kelly, M.; Bewley, C.A. Mirabamides A-D, depsipeptides from the sponge Siliquariaspongia mirabilis that inhibit HIV-1 fusion. J. Nat. Prod. 2007, 70, 1753-1760.
83. Donia, M.S.; Wang, B.; Dunbar, D.C.; Desai, P.V.; Patny, A.; Avery, M.; Hamann, M.T. Mollamides B and C, cyclic hexapeptides from the Indonesian tunicate Didemnum molle. J. Nat. Prod. 2008, 71, 941-945.
84. Andjelic, C.; Planelles, V.; Barrows, L. Characterizing the anti-HIV activity of papuamide A. Mar. Drugs 2008, 6, 528-549.
85. Ratnayake, A.S.; Bugni, T.S.; Feng, X.; Harper, M.K.; Skalicky, J.J.; Mohammed, K.A.; Andjelic, C.D.; Barrows, L.R.; Ireland, C.M. Theopapuamide, a cyclic depsipeptide from a Papua New Guinea Lithistid sponge Theonella swinhoei. J. Nat. Prod. 2006, 69, 1582-1586.
86. He, F.; Bao, J.; Zhang, X.Y.; Tu, Z.C.; Shi, Y.M.; Qi, S.H. Asperterrestide A, a cytotoxic cyclic tetrapeptide from the marine-derived fungus Aspergillus terreus SCSGAF0162. J. Nat. Prod. 2013, 76, 1182-1186.
87. Zampella, A.; Sepe, V.; Bellotta, F.; Luciano, P.; D'Auria, M.V.; Cresteil, T.; Debitus, C.; Petek, S.; Poupat, C.; Ahond, A. Homophymines B-E and A1-E1, a family of bioactive cyclodepsipeptides from the sponge Homophymia sp. Org. Biomol. Chem. 2009, 7, 4037-4044.
88. Zampella, A.; Sepe, V.; Luciano, P.; Bellotta, F.; Monti, M.C.; D'Auria, M.V.; Jepsen, T.; Petek, S.; Adeline, M.-T.; Laprevote, O.; et al. Homophymine A, an anti-HIV cyclodepsipeptide from the sponge Homophymia sp. J. Org. Chem. 2008, 73, 5319-5327.
89. Araki, T.; Matsunaga, S.; Nakao, Y.; Furihata, K.; West, L.; Faulkner, D.J.; Fusetani, N. Koshikamide B, a cytotoxic peptide lactone from a marine sponge Theonella sp. J. Org. Chem. 2008, 73, 7889-7894.
90. Plaza, A.; Bifulco, G.; Masullo, M.; Lloyd, J.R.; Keffer, J.L.; Colin, P.L.; Hooper, J.N.A.; Bell, L.J.; Bewley, C.A. Mutremdamide A and koshikamides C-H, peptide inhibitors of HIV-1 entry from different Thennella species. J. Org. Chem. 2010, 75, 4344-4355.
91. Bradshaw, J. Cationic antimicrobial peptides: Issues for potential clinical use. BioDrugs 2003, 17, 233-240.
92. Ovchinnikova, T.V.; Shenkarev, Z.O.; Balandin, S.V.; Nadezhdin, K.D.; Paramonov, A.S.; Kokryakov, V.N.; Arseniev, A.S. Molecular insight into mechanism of antimicrobial action of the beta-hairpin peptide arenicin: Specific oligomerization in detergent micelles. Biopolymers 2008, 89, 455-464.
93. Yederi, R.; Reddy, K. Purification and characterization of antibacterial proteins from granular hemocytes of Indian mud crab, Scylla serrata. Acta Biochim. Pol. 2009, 56, 71-82.
94. Cude, W.N.; Mooney, J.; Tavanaei, A.A.; Hadden, M.K.; Frank, A.M.; Gulvik, C.A.; May, A.L.; Buchan, A. Production of the antimicrobial secondary metabolite indigoidine contributes to competitive surface colonization by the marine roseobacter Phaeobacter sp. strain Y4I. Appl. Environ. Microbiol. 2012, 78, 4771-4780.
95. Dahiya, R.; Gautam, H. Toward the synthesis and biological screening of a cyclotetrapeptide from marine bacteria. Mar. Drugs 2011, 9, 71-81.
96. Binz, T.M.; Maffioli, S.I.; Sosio, M.; Donadio, S.; Muller, R. Insights into an unusual nonribosomal peptide synthetase biosynthesis. J. Biol. Chem. 2010, 285, 32710-32719.
97. Dahiya, R. Cyclopolypeptides with antifungal interest. Coll. Pharm. Commun. 2013, 1, 1-15.
98. Diehl, K.B. Topical Antifungal Agents: An Update. Am. Fam. Phys. 1996, 54, 1687-1692.
99. Onishi, J.; Meinz, M.; Thompson, J.; Curotto, J.; Dreikorn, S.; Rosenbach, M.; Douglas, C.; Abruzzo, G.; Tsipouras, A.; Wilson, K.; et al. Discovery of novel antifungal (1,3)-beta- D-glucan synthase inhibitors. Antimicrob. Agents Chemother. 2000, 44, 368-377.
100. Jang, W.S.; Kim, C.H.; Kang, M.S.; Chae, H.J.; Son, S.M.; Seo, S.J.; Lee, I.H. cDNA cloning of halocidin and a new antimicrobial peptide derived from the N-terminus of Ci-META4. Peptides 2005, 26, 2360-2367.
101. Liu, X.; Ren, B.; Gao, H.; Liu, M.; Dai, H.; Song, F.; Yu, Z.; Wang, S.; Hu, J.; Kokare, C.R.; Zhang, L. Optimization for the production of surfactin with a new synergistic antifungal activity. PLoS One 2012, 7, e34430.
102. Shilabin, A.G.; Hamann, M.T. In vitro and in vivo evaluation of select kahalalide F analogs with antitumor and antifungal activities. Bioorg. Med. Chem. 2011, 19, 6628-6632.
103. World Health Organization. Available online: http://www.who.int/neglected-diseases/en/ (accessed on 14 October 2014).
104. Penet, M.F.; Kober, F.; Confort-Gouny, S.; Le Fur, Y.; Dalmasso, C.; Coltel, N.; Liprandi, A.; Gulian, J.M.; Grau, G.E.; Cozzone, P.J.; et al. Magnetic resonance spectroscopy reveals an impaired brain metabolic profile in mice resistant to cerebral malaria infected with Plasmodium berghei ANKA. J. Biol. Chem. 2007, 282, 14505-14514.
105. Snow, R.W.; Guerra, C.A.; Noor, A.M.; Myint, H.Y.; Hay, S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434, 214-217.
106. Mishra, S.K.; Satpathy, S.K.; Mohanty, S. Survey of malaria treatment and deaths. Bull. World Health Organ. 1999, 77, 1020.
107. Plebanski, M.; Locke, E.; Kazura, J.W.; Coppel, R.L. Malaria vaccines: Into a mirror, darkly? Trends Parasitol. 2008, 24, 532-536.
108. Schlitzer, M. Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development . ChemMedChem 2007, 2, 944-986.
109. Schlitzer, M. Antimalarial drugs-what is in use and what is in the pipeline. Archiv. Der Pharmazie 2008, 341, 149-163.
110. Cheng, G.; Montero, A.; Gastaminza, P.; Whitten-Bauer, C.; Wieland, S.F.; Isogawa, M.; Fredericksen, B.; Selvarajah, S.; Gallay, P.A.; Ghadiri, M.R.; et al. A virocidal amphipathic alpha-helical peptide that inhibits hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA 2008, 105, 3088-3093.
111. Bai, F.; Town, T.; Pradhan, D.; Cox, J.; Ashish; Ledizet, M.; Anderson, J.F.; Flavell, R.A.; Krueger, J.K.; Koski, R.A.; et al. Antiviral peptides targeting the West Nile virus envelope protein. J. Virol. 2007, 81, 2047-2055.
112. Budge, P.J.; Graham, B.S. Inhibition of respiratory syncytial virus by RhoA-derived peptides: Implications for the development of improved antiviral agents targeting heparin-binding viruses. J. Antimicrob. Chemother. 2004, 54, 299-302.
113. Cooper, D.A.; Lange, J.M. Peptide inhibitors of virus-cell fusion: Enfuvirtide as a case study in clinical discovery and development. Lancet Infect. Dis. 2004, 4, 426-436.
114. Altmann, S.E.; Jones, J.C.; Schultz-Cherry, S.; Brandt, C.R. Inhibition of vaccinia virus entry by a broad spectrum antiviral peptide. Virology 2009, 388, 248-259.
115. Lu, Z.; van Wagoner, R.M.; Harper, M.K.; Baker, H.L.; Hooper, J.N.A.; Bewley, C.A.; Ireland, C.M. Mirabamides E-H, HIV-inhibitory depsipeptides from the sponge Stelletta clavosa . J. Nat. Prod. 2011, 74, 185-193.
116. Elyakova, L.A.; Vaskovsky, B.V.; Khoroshilova, N.I.; Vantseva, S.I.; Agapkina, Y.Y. Isolation and structure of a novel peptide inhibitor of HIV-1 integrase from marine polychaetes. Russ. J. Bioorg. Chem. 2011, 37, 207-216.